Preoperative Chemotherapy for Operable Colon Cancer: Mature Results of an International Randomized Controlled Trial

PURPOSE Neoadjuvant chemotherapy (NAC) has potential advantages over standard postoperative chemotherapy for locally advanced colon cancer but requires formal evaluation. METHODS Patients with radiologically staged T3-4, N0-2, M0 colon cancer were randomly allocated (2:1) to 6 weeks oxaliplatin-fluoropyrimidine preoperatively plus 18 postoperatively (NAC group) or 24 weeks postoperatively…

Read the full article here

Source: Journal of Clinical Oncology

Categories: Hem/Oncs, Latest Headlines

Tags: cancer, coloncancer, GI23

Tweets with this article

Ryan Nipp, MD, MPH

Preoperative Chemotherapy for Operable Colon #Cancer: Mature Results of an International Randomized Controlled Trial. https://t.co/lutohxTwy2 #GI23 #ColonCancer @ASCO @JCO_ASCO https://t.co/fSf8cItgCB

Exploring the Language Used to Describe Older Patients at Multidisciplinary Cancer Conferences

Older adults with cancer often present with distinct complexities that complicate their care, yet the language used to discuss their management at multidisciplinary cancer conferences…

Ryan Nipp MD, MPH May 1, 2024

Exploring the Language Used to Describe Older Patients at Multidisciplinary Cancer Conferences

Older adults with cancer often present with distinct complexities that complicate their care, yet the language used to discuss their management at multidisciplinary cancer conferences…

Ryan Nipp MD, MPH April 28, 2024

Association of food insecurity with overall and disease-specific mortality among cancer survivors in the US

Supportive Care in Cancer – To investigate the association of food insecurity with overall and disease-specific mortality among US cancer survivors. Data from the National…

Ryan Nipp MD, MPH April 27, 2024

Loneliness and Mortality Risk Among Cancer Survivors in the United States: A Retrospective, Longitudinal Study

Background: Loneliness, a subjective feeling of being isolated, is a prevalent concern for elderly people and more so among cancer survivors because a cancer diagnosis…

Ryan Nipp MD, MPH April 27, 2024

The Myth of the Free Market for Pharmaceuticals | NEJM

The U.S. pharmaceutical market has always been influenced by government. The 2022 Inflation Reduction Act is the latest policy aiming to improve access and affordability…

Ryan Nipp MD, MPH April 25, 2024

Opportunities for Expanding the Integration of Palliative Care in Oncology Care | Journal of Palliative Medicine

Patients with cancer and their families comprise a significant population served by palliative care. Close collaboration between oncology clinicians and palliative care teams has demonstrated…

Ryan Nipp MD, MPH April 20, 2024

Patient-Reported Outcomes as a Recruitment Strategy for Clinical Trial Enrollment

This study examines the association between electronic patient-reported outcome–prompted recruitment strategies and clinical trial enrollment.

Ryan Nipp MD, MPH April 13, 2024

Patient-Reported Outcomes as a Recruitment Strategy for Clinical Trial Enrollment

This study examines the association between electronic patient-reported outcome–prompted recruitment strategies and clinical trial enrollment.

Ryan Nipp MD, MPH April 13, 2024

Do goals of care documentation reflect the conversation?: Evaluating conversation‐documentation accuracy

Journal of the American Geriatrics Society (JAGS) is the go-to geriatrics journal for clinical aging research including education, clinical practice and public policy.

Ryan Nipp MD, MPH April 12, 2024

Clinical Benefit and Regulatory Outcomes of Cancer Drugs Receiving Accelerated Approval

This study aims to determine whether cancer drugs granted accelerated approval from the US Food and Drug Administration ultimately demonstrate clinical benefit and to evaluate…

Ryan Nipp MD, MPH April 8, 2024

Related Articles